RNA Virus Infections: all 98 studies

Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• A Study of COVID-19 Vaccine(s) in Children and AdultsRecruitingNCT07798648Phase 3
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of AgeRecruitingNCT07730450Phase 4
• Therapeutics for Moderate and Severe DengueNot yet recruitingNCT07543458Phase 3
• A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedRecruitingNCT07013474Phase 3
• A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune ResponsesRecruitingNCT06810934Phase 1/2
• A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruitingNCT06679140Phase 3
• Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation XchangeEnrolling by invitationNCT05534425Not applicable
• Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)CompletedNCT06729606Phase 3Results posted
• Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)CompletedNCT06729593Phase 3Results posted
• Stellate Ganglion Block for COVID-induced ParosmiaCompletedNCT06253806Phase 2Results posted
• PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)TerminatedNCT05780541Phase 3Results posted
• MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780463Phase 3Results posted
• AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780437Phase 3Results posted
• BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780424Phase 3Results posted
• VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780281Phase 3Results posted
• LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780268Phase 3Results posted
• A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or UnprimedCompletedNCT05422326Phase 2Results posted
• A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult ParticipantsActive, not recruitingNCT05217641Phase 1Results posted
• Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and TuberculosisCompletedNCT05065905Phase 1/2Results posted
• Vaccination for Recovered Inpatients With COVID-19 (VATICO)CompletedNCT04969250Phase 4Results posted
• A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial SubjectsCompletedNCT04949490Phase 2Results posted
• ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19CompletedNCT04843761Phase 3Results posted
• Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in MenCompletedNCT04772469Not applicableResults posted
• Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)TerminatedNCT04664075Results posted
• A Phase III Clinical Study to Evaluate SYN023's Efficacy and SafetyCompletedNCT04644484Phase 3Results posted
• ACTIV-2: A Study for Outpatients With COVID-19CompletedNCT04518410Phase 2/3Results posted
• A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised AdultsCompletedNCT04380701Phase 1/2Results posted
• Convalescent Plasma Collection and Treatment in Pediatrics and AdultsCompletedNCT04376034Phase 3Results posted
• Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19TerminatedNCT04365101Phase 1/2Results posted
• Healthcare Worker Exposure Response and Outcomes of HydroxychloroquineCompletedNCT04334148Phase 3Results posted
• Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the ElderlyCompletedNCT03739112Phase 3Results posted
• The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial VirusCompletedNCT03728413Not applicableResults posted
• Effectiveness & Implementation of a Behavioral Intervention for Adherence and Substance Use in HIV Care in South AfricaCompletedNCT03529409Not applicableResults posted
• Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy AdultsCompletedNCT03321968Phase 3Results posted
• Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in AdultsCompletedNCT03301051Phase 3Results posted
• Panblok H7 Vaccine Adjuvanted With AS03 or MF59CompletedNCT03283319Phase 2Results posted
• VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and AdolescentsCompletedNCT03110770Phase 2Results posted
• Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated CirrhosisCompletedNCT02996682Phase 3Results posted
• Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy SubjectsTerminatedNCT02696291Phase 1Results posted
• Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)TerminatedNCT02613403Phase 2Results posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation SettingCompletedNCT02350569Phase 2Results posted
• Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus InfectionCompletedNCT02185794Phase 1Results posted
• Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy SubjectsCompletedNCT02061358Phase 1Results posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)CompletedNCT01851330Phase 3Results posted
• Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) InfectionCompletedNCT01838590Phase 3Results posted
• Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3CompletedNCT01808248Phase 2Results posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV InfectionCompletedNCT01768286Phase 3Results posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCVCompletedNCT01701401Phase 3Results posted
• A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of IbuzatrelvirCompletedNCT07552779Phase 1
• Effectiveness of Ammonium Chloride in Reducing Viral LoadCompletedNCT07254052
• RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory InfectionCompletedNCT06149494Phase 2
• Project Khanya: Peer-Delivered Intervention to Improve HIV Medication Adherence and Substance Use in South AfricaActive, not recruitingNCT05933226Not applicable
• Assessment of Long-term Sequelae of Coronavirus Disease 2019 (COVID-19) Pneumonia With Chest CT and Pulmonary Function TestsActive, not recruitingNCT05835128
• Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)Status unknownNCT05394623
• Integrating Enhanced HIV PrEP Into a STI Clinic in LilongweCompletedNCT05307991
• Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone StudyCompletedNCT05284097Phase 2
• Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & OropharynxCompletedNCT04872686Phase 3
• EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19CompletedNCT04822818Phase 3
• Prevalence and Risk Factors of COVID-19 in the Upper Silesian AgglomerationStatus unknownNCT04627623
• COVID-19 and SARS-CoV-2 Detection in SalivaCompletedNCT04517682
• ACTIV-3: Therapeutics for Inpatients With COVID-19CompletedNCT04501978Phase 3
• Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19CompletedNCT04476979Phase 2
• Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)Status unknownNCT04463264Phase 2/3
• ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19CompletedNCT04367740
• Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior ExposureCompletedNCT04144348Phase 1
• Venezuelan Equine Encephalitis Monovalent Virus-Like Particle VaccineStatus unknownNCT03776994Phase 1
• Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to EliminationStatus unknownNCT03776760
• DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant RecipientsCompletedNCT03642977
• Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)CompletedNCT03392207
• A Double-blind Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-LyoCompletedNCT03333538Phase 1/2
• Centralized Reminder Recall - Flu RCT2CompletedNCT03294473Not applicable
• Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly AdultsCompletedNCT02831751Phase 2
• Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy AdultsCompletedNCT02768805Phase 2
• Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima PeruCompletedNCT02630082Not applicable
• Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected PatientsActive, not recruitingNCT02500849Phase 1
• Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly PopulationCompletedNCT02236052Phase 2
• Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in AdultsCompletedNCT02233816Phase 2
• Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected AdultsStatus unknownNCT02231281Phase 3
• Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis CTerminatedNCT02120274Phase 4
• Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C VirusCompletedNCT02098616Not applicable
• Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802TerminatedNCT02041715Phase 1
• Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.CompletedNCT02022163Phase 1
• Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in AdultsCompletedNCT01991587Phase 1/2
• Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.CompletedNCT01991561Phase 2
• Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIVCompletedNCT01946594Phase 4
• Clinic-based ART Diagnostic EvaluationCompletedNCT01791556Not applicable
• Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis CApproved for marketingNCT01779518
• Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAARTCompletedNCT01680094Phase 1/2
• Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological MechanismsCompletedNCT01641094
• DNA-based Influenza Vaccine in the ElderlyCompletedNCT01587131Phase 1
• Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/BCompletedNCT01431768Not applicable
• Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy AdultsCompletedNCT01418235Phase 1
• Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 StudyCompletedNCT01251133Phase 3
• Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza VaccineCompletedNCT01244867Phase 2
• Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)Status unknownNCT01230580Phase 4
• A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral TherapyTerminatedNCT01026727Phase 2
• Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy AdultsCompletedNCT00984945Phase 1
• Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis CCompletedNCT00593151Phase 1/2

← RNA Virus Infections overview